About
Owkin exists to find the right treatment for every patient. Our focus is to use artificial intelligence to discover and develop better treatments for unmet medical needs, starting with the fight against cancer.
In November, Owkin became a 'unicorn' - a startup worth more than $1 billion - through a $180 million investment from pharmaceutical company Sanofi. As a result, we are now looking for the brightest and best talent to help us to go even further in achieving our mission.